Barbara Ann Jacobsmeyer
CIK 1691132 · View on SEC EDGAR ↗
First SEC filing: Dec. 30, 2016 · Latest: Jan. 13, 2023
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2020 | EHC | S | 2,500 | $64.73 | $161,825 | 44,761 Direct | -5.29% | Disposed | 138.2% (price as of 2026-08-20) |
| May 14, 2018 | EHC | S | 1,798 | $62.73 | $112,789 | 32,269 Direct | -5.28% | Disposed | 145.8% (price as of 2026-08-20) |
| May 2, 2018 | EHC | S | 3,897 | $62.51 | $243,601 | 34,067 Direct | -10.26% | Disposed | 146.6% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 1, 2022 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock (22,137) | $66.39 | March 1, 2032 | 22,137 | Acquired |
| March 2, 2021 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock (16,620) | $80.40 | March 2, 2031 | 16,620 | Acquired |
| March 2, 2020 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock (17,227) | $76.54 | March 2, 2030 | 17,227 | Acquired |
| March 1, 2019 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock (14,237) | $63.77 | March 1, 2029 | 14,237 | Acquired |
| May 2, 2018 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock (3,897) | $42.22 | Feb. 24, 2027 | 3,897 | Disposed |
| March 1, 2018 | EHC | Non-qualified Stock Option (Right to Buy) | Healthsouth Common Stock (12,151) | $53.79 | March 1, 2028 | 12,151 | Acquired |
| Feb. 24, 2017 | EHC | Non-qualified Stock Option (Right to Buy) | Healthsouth Common Stock (11,689) | $42.22 | Feb. 24, 2027 | 11,689 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 30, 2016 | EHC | Healthsouth Common Stock | 19,140 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $375,000 | — | $1,580,565 | $382,718 | — | — | $37,642 | $2,375,925 |
| 2021 | $703,846 | — | $1,303,548 | $319,295 | $871,386 | — | $143,320 | $3,341,395 |
| 2020 | $620,000 | — | $1,211,485 | $266,742 | $497,250 | — | $26,963 | $2,622,440 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.